Lupin shares lost 2.8 percent intraday Friday after sources told CNBC-TV18 that the US health regulator will begin inspection of company's Pithampur (in Madhya Pradesh) unit 1 from Monday, July 24.
Company's unit 2 & 3 at Pithampur was inspected by US Food and Drug Administration earlier this year.
Unit 2 was inspected by the regulator from May 8-19 and issued 6 observations while unit 3 was inspected from June 12-16 and received 5 observations.
It is learnt that around 40-50 percent of pending ANDAs have been filed from Goa plant.
At 15:03 hours IST, the stock price was quoting at Rs 1,140.00, down Rs 26.00, or 2.23 percent on the BSE.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!